Title:
PERSONALIZED FUSION CELL VACCINES
Document Type and Number:
WIPO Patent Application WO/2022/104104
Kind Code:
A3
Abstract:
The present invention provides compositions and methods for treating cancer.
More Like This:
Inventors:
AVIGAN DAVID (US)
ROSENBLATT JACALYN (US)
KUFE DONALD (US)
ROSENBLATT JACALYN (US)
KUFE DONALD (US)
Application Number:
PCT/US2021/059199
Publication Date:
June 23, 2022
Filing Date:
November 12, 2021
Export Citation:
Assignee:
DANA FARBER CANCER INST INC (US)
BETH ISRAEL DEACONESS MEDICAL CT INC (US)
AVIGAN DAVID (US)
ROSENBLATT JACALYN (US)
KUFE DONALD (US)
BETH ISRAEL DEACONESS MEDICAL CT INC (US)
AVIGAN DAVID (US)
ROSENBLATT JACALYN (US)
KUFE DONALD (US)
International Classes:
A61K39/00; A61P35/00; C07K14/725; C07K16/28; C12N5/0783; C12N5/16
Foreign References:
| CN108148812A | 2018-06-12 |
Other References:
CAPELLETTI MARZIA ET AL: "Potent Synergy between Combination of Chimeric Antigen Receptor (CAR) Therapy Targeting CD19 in Conjunction with Dendritic Cell (DC)/Tumor Fusion Vaccine in Hematological Malignancies", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 134, 13 November 2019 (2019-11-13), pages 3227, XP086667495, ISSN: 0006-4971, DOI: 10.1182/BLOOD-2019-124944
COREY M MUNGER ET AL: "Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma", CANCER IMMUNOLOGY, IMMUNOTHERAPY, SPRINGER, BERLIN, DE, vol. 61, no. 10, 23 March 2012 (2012-03-23), pages 1819 - 1832, XP035115258, ISSN: 1432-0851, DOI: 10.1007/S00262-012-1229-1
SHI WEI ET AL: "A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine", CANCER LETTERS, NEW YORK, NY, US, vol. 522, 23 September 2021 (2021-09-23), pages 184 - 197, XP086814501, ISSN: 0304-3835, [retrieved on 20210923], DOI: 10.1016/J.CANLET.2021.09.028
COREY M MUNGER ET AL: "Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma", CANCER IMMUNOLOGY, IMMUNOTHERAPY, SPRINGER, BERLIN, DE, vol. 61, no. 10, 23 March 2012 (2012-03-23), pages 1819 - 1832, XP035115258, ISSN: 1432-0851, DOI: 10.1007/S00262-012-1229-1
SHI WEI ET AL: "A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine", CANCER LETTERS, NEW YORK, NY, US, vol. 522, 23 September 2021 (2021-09-23), pages 184 - 197, XP086814501, ISSN: 0304-3835, [retrieved on 20210923], DOI: 10.1016/J.CANLET.2021.09.028
Attorney, Agent or Firm:
SMITH, DeAnn, F. et al. (US)
Download PDF:
Previous Patent: VIBRATING BALL ASSEMBLY WITH REDUCED VIBRATION SECTION
Next Patent: NICOTINAMIDE DINUCLEOTIDE (NAD) DETECTION AND QUANTIFICATION
Next Patent: NICOTINAMIDE DINUCLEOTIDE (NAD) DETECTION AND QUANTIFICATION